欧洲蛋白质定序市场按应用、最终用户和国家划分 - 分析和预测（2024-2033）

预计到 2033 年，欧洲蛋白质定序市场规模将从 2024 年的 4.772 亿美元增至 6.856 亿美元，2024-2033 年预测期内的复合年增长率为 4.11%。

蛋白质定序是确定蛋白质中胺基酸的精确顺序的过程，对于了解蛋白质的结构、功能和在生物系统中的作用至关重要。它们在生物技术、生物医学研究、药物发现和疾病诊断中发挥关键作用，并为精准医疗和标靶治疗的进步做出了重大贡献。蛋白质定序为转译后修饰、蛋白质相互作用和疾病机制提供了宝贵的见解，有助于生命科学和医疗保健领域的突破。

在欧洲，由于对蛋白质体学研究的投入不断增加、生物製药行业的不断扩张以及个人化医疗的需求不断增加，蛋白质定序的采用正在加速。两种主要的定序技术分别是对小蛋白质有效的Edman降解技术和因高通量和分析复杂样本的能力而被广泛用于大规模蛋白质体学的质谱技术。市场包括促进定序过程的仪器、试剂和消耗品，以及提供专业定序服务的受託研究机构。

对生物标记发现、药物开发和疾病诊断的需求不断增长，推动着蛋白质定序技术的不断创新。在政府的大力支持、不断增加的私人投资和强大的研究生态系统的帮助下，欧洲在蛋白质组学和基于蛋白质的研究方面有望实现显着增长。

欧洲蛋白质定序市场正在稳步增长，这得益于蛋白质组学研究的投资增加、生物製药行业的不断扩张以及个人化医疗需求的不断增长。蛋白质定序可以确定蛋白质中胺基酸的精确顺序，对于了解蛋白质的结构、功能和相互作用至关重要。它们在药物发现、疾病诊断和生物标记识别中发挥关键作用，支持精准医疗和标靶治疗的进步。

市场发展主要受到质谱和 Edman 降解等定序技术的进步的推动。质谱法因其能够有效分析复杂的蛋白质样本而广泛应用于高通量蛋白质体学，而埃德曼降解法对于较小蛋白质的序列测定仍具有相关性。在欧洲，在政府资助以及研究机构、製药和生物技术公司之间的合作的推动下，对创新的高度重视正在刺激该领域的进一步发展。

推动市场成长的关键因素包括肿瘤学、神经退化性疾病和感染疾病研究领域的应用不断扩大。此外，人工智慧和机器学习越来越多地被应用于蛋白质组学以增强资料分析能力。凭藉成熟的研究生态系统和不断增长的生命科学投资，欧洲蛋白质定序市场有望实现长期扩张，并将塑造蛋白质组学和生物医学研究的未来。

本报告研究了欧洲蛋白质定序市场，并提供了市场概述、应用、最终用户和国家/地区趋势以及参与市场的公司概况。

目录

执行摘要

第 1 章欧洲蛋白质定序市场概述

• 趋势：当前和未来的影响评估
• 蛋白质序列测定工作流程
• 法律规范
• 市场动态概览

2. 蛋白质定序市场（按地区划分），百万美元，2022-2033 年

• 区域摘要
• 欧洲
  • 区域概况
  • 市场成长动力
  • 成长抑制因素
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他的

第三章 市场-竞争格局

• 欧洲蛋白质定序市场：竞争格局
  • 企业策略 2021 年 1 月 - 2024 年 9 月
  • 伙伴关係、合作和业务扩展
• 公司简介
  • Merck KGaA
  • Proteome Factory AG
  • Selvita SA

第四章调查方法

Introduction to Europe Protein Sequencing Market

The Europe protein sequencing market is projected to reach $685.6 million by 2033 from $477.2 million in 2024, growing at a CAGR of 4.11% during the forecast period 2024-2033. Protein sequencing is the process of determining the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It plays a crucial role in biotechnology, biomedical research, drug discovery, and disease diagnostics, significantly contributing to advancements in precision medicine and targeted therapies. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In Europe, the adoption of protein sequencing is accelerating, driven by growing investments in proteomics research, the expansion of the biopharmaceutical industry, and increasing demand for personalized medicine. The two primary sequencing techniques are Edman degradation, which is effective for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market comprises instruments, reagents, and consumables that facilitate sequencing processes, alongside contract research organizations providing specialized sequencing services.

Rising demand for biomarker discovery, drug development, and disease diagnostics is driving continuous innovation in protein sequencing technologies. With strong government support, increasing private-sector investments, and a robust research ecosystem, Europe is poised for significant growth in proteomics and protein-based research.

Market Introduction

The Europe protein sequencing market is experiencing steady growth, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and the rising demand for personalized medicine. Protein sequencing, which determines the precise order of amino acids in a protein, is essential for understanding protein structures, functions, and interactions. It plays a crucial role in drug discovery, disease diagnostics, and biomarker identification, supporting advancements in precision medicine and targeted therapies.

The market is primarily driven by advancements in sequencing technologies such as mass spectrometry and Edman degradation. Mass spectrometry is widely used for high-throughput proteomics due to its ability to analyze complex protein samples efficiently, while Edman degradation remains relevant for sequencing smaller proteins. Europe's strong focus on innovation, supported by government funding and collaborations between research institutions, pharmaceutical companies, and biotechnology firms, is fostering further developments in this field.

Key factors propelling market growth include increasing applications in oncology, neurodegenerative diseases, and infectious disease research. Additionally, the rising adoption of artificial intelligence and machine learning in proteomics is enhancing data analysis capabilities. With a well-established research ecosystem and growing investments in life sciences, the European protein sequencing market is poised for long-term expansion, shaping the future of proteomics and biomedical research.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Selvita
• Merck KGaA
• Proteome Factory AG

Table of Contents

Executive Summary

Scope and Definition

1 Europe Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.1.1 EU Medical Device Regulation
      • 1.3.1.1.2 EU In Vitro Diagnostic Regulation
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing

Labs in the EU 26

• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Europe Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Protein Sequencing Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Germany
  • 2.2.5 U.K.
  • 2.2.6 France
  • 2.2.7 Italy
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Landscape

• 3.1 Europe Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
  • 3.1.2 Partnerships, Alliances, and Business Expansions
• 3.2 Company Profiles
  • 3.2.1 Merck KGaA
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Proteome Factory AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Services Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 Selvita S.A.
    • 3.2.3.1 Overview
    • 3.2.3.2 Services Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Europe Protein Sequencing Market, $Million, 2024, 2028, and 2033
• Figure 2: Protein Sequencing Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Europe Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Europe Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 5: Key Events to Keep Track of in the Protein Sequencing Market
• Figure 6: Protein Sequencing Workflow Overview
• Figure 7: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
• Figure 8: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
• Figure 9: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 10: Germany Protein Sequencing Market, $Million, 2022-2033
• Figure 11: U.K. Protein Sequencing Market, $Million, 2022-2033
• Figure 12: France Protein Sequencing Market, $Million, 2022-2033
• Figure 13: Italy Protein Sequencing Market, $Million, 2022-2033
• Figure 14: Spain Protein Sequencing Market, $Million, 2022-2023
• Figure 15: Rest-of-Europe Protein Sequencing Market, $Million, 2022-2033
• Figure 16: Corporate Strategies, January 2021- September 2024
• Figure 17: Data Triangulation
• Figure 18: Top-Down and Bottom-Up Approach
• Figure 19: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Europe Protein Sequencing Market Opportunities
• Table 3: Product Launches, January 2023-September 2024
• Table 4: Companies Providing Single-Molecule Protein Sequencing
• Table 5: List of Molecular Targets Identified with Proteomics
• Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
• Table 7: Europe Protein Sequencing Market (by End User), $Million, 2022-2033
• Table 8: Europe Protein Sequencing Market (by Application), $Million, 2022-2033
• Table 9: Partnerships, Alliances, and Business Expansions (by Company), January 2021-September 2024